business
Murthy's return won't work like magic wand for Infy: Biocon
Kiran Mazumdar Shaw, MD, Biocon says Narayana Murthy's return would have probably been a tough decision, as most succession plans are and will undoubtedly help boost investor and employee confidence.
first published: Jun 1, 2013 04:23 pm